the EAHAD Podcast
By EAHAD - European Association for Haemophilia and Allied Disorders
the EAHAD PodcastMay 08, 2023
E-Learning WG Podcast/Episode 2: ITI in the era of emicizumab
Welcome to the second module of the EAHAD E-Learning Working Group podcast, where we are excited to feature Carmen Escuriola-Ettingshausen as our guest speaker. In this episode, Carmen will be discussing the topic of "ITI in the era of emicizumab." Emicizumab, a new therapeutic option for people with hemophilia A, has introduced new challenges for clinicians and patients, particularly in the realm of immune tolerance induction therapy. Carmen will delve into the impact of emicizumab on ITI therapy and provide practical insights into managing patients undergoing this treatment. So, sit back, relax, and join us in this insightful conversation with Carmen Escuriola-Ettingshausen. Do not forget to watch the full webinar on EAHAD Academy: https://academy.eahad.org/eahad/2023/module-2-iti-in-the-era-of-emicizumab/376716/carmen.escuriola-ettingshausen.module.2.iti.in.the.era.of.emicizumab.html?f=menu%3D25%2Ac_id%3D376716%2Afeatured%3D18172
E-Learning WG Podcast/Episode 1: How to manage acute cardiovascular disorders in haemophilia
Welcome to the first episode of the EAHAD Podcast, where we bring you expert insights on bleeding and clotting disorders. In this episode, we focus on the management of acute cardiovascular disorders in patients with haemophilia. Our speakers, Robert Klamroth and Cedric Hermans, are renowned experts in this field and will provide a comprehensive overview of the topic.
During this episode, Cedric Hermans and Robert Klamroth will introduce the background of cardiovascular disease in haemophilia and discuss the management of a specific patient. They will also review recent literature and recommendations on this topic, highlighting the complexity of anticoagulation and antiplatelet treatment in patients with haemophilia.
This podcast will be of interest to healthcare professionals who manage patients with bleeding disorders and cardiovascular diseases. We invite you to watch the full module on the EAHAD Academy: academy.eahad.org/eahad/2023/elearning-working-group/module1